PATENT CLAIM ANALYSIS

Application Number: 16329399
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-07
Patent Classification: ["514", "092000"]

Abstract:
Disclosed are compounds of Formula (I), Formula (II), Formula (III), and Formula (IV) or salts thereof, wherein R 2  is —OH or —OP(O)(OH) 2 ; and R 1  is defined herein. Also disclosed are methods of using such compounds as selective agonists for G protein coupled receptor S1P 1 , and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing the progression of diseases or disorders in a variety of therapeutic areas, such as autoimmune diseases and vascular disease.

Claim (Index 4):
The compound according to  claim 3  wherein said compound is (1-amino-3-(3-(5-hexyl-4-(trifluoromethyl)isoxazol-3-yl)-4,5-dihydronaphtho[1,2-c]isoxazol-7-yl) cyclopentyl)methanol (22 to 25); or (1-amino-3-(3-hexyl-4,5-dihydronaphtho[1,2-c]isoxazol-7-yl)cyclopentyl)methyl dihydrogen phosphate (41-45).

Metadata:
- Claim Count in Document: 3.0
- Percentile: 99.0
- Lexical Diversity: 1.71429
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13504541', '13811032', '13883358', '13145730', '15337843']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8038458372070542
- 35 USC 102 Novelty (BERT): 0.5787021314734679
- Combined Prediction Score: 0.7813314666336955
- Mean Citation Score: 364.75398
- Max Citation Score: 498.36066
- Similarity Product: 394.9804183471441

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test